Slashdot is powered by your submissions, so send in your scoop


Forgot your password?
Slashdot Deals: Cyber Monday Sale Extended! Courses ranging from coding to project management - all eLearning deals 20% off with coupon code "CYBERMONDAY20". ×
Medicine Science

Common Diabetic Drug Fights Cancer Stem Cells 149

SubtleGuest writes "In the latest issue of Cancer Research, a breakthrough study shows that Metformin, a cheap and common diabetic medicine, kills cancer stem cells — the cells postulated to be responsible for tumor resistance and recurrence after chemotherapy (research abstract here). It has been known that diabetics taking Metformin experience lower cancer rates, and now it is apparent why that may be and how it may apply to non-diabetics as well. When combined with Doxorubicin to kill non-stem cancer cells, the results are nothing short of astonishing: total remission in a mouse xenograft model. The results are achieved at levels below the dosage needed for diabetic control, opening many new avenues in cancer treatment and prevention."
This discussion has been archived. No new comments can be posted.

Common Diabetic Drug Fights Cancer Stem Cells

Comments Filter:

"Everybody is talking about the weather but nobody does anything about it." -- Mark Twain